BCMA-PD1-CART cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BCMA-PD1-CART cells, covering 2019-11-18 to 2019-11-18. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficiency Study of BCMA-PD1-CART Cells in Relapsed/Refractory Multiple Myeloma [Phase 2]